Agile Therapeutics, Inc AGRX

Rocky88888888888 Premium

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other...

Traspe Premium

Hi my friend this is very interesting STOCKS for acumulation very low buy price with potencial biger profit. Check my analyze.

TradeThePool

Hi traders, The consumer sector has been in a sharp decline in recent days and we have a trading idea in AGRX for further declines. AGRX tried to move up and failed, broke the support level yesterday, and is now trading below it. Our idea is to take AGRX if it breaks the $ 1.97 price for further declines to the $ 1.5 range.

ALEXSTOXCOM Premium

AGRX volume has significantly increased in the last 2 days. There is a very high potencial to go to min. 5 USD level. Insiders were buying in January. MArket capoitalization is just 6 MIl. EUR. Revenue is going up. Profit margin is improving.

Rybkarybka

hope for another breakout from the downtrend with earnings and set new utrend . accumulating for long first PT 1,26. pt2. 1,9 pr3. 2,6 52w low- 0,65 52 high 3,75 almost 80% drop ... ...its time to make some money back... BOUGHT AT 0,66 12.10.21

Joshh_Tradess

Butterfly harmonic w/ a dragon pattern along a horizontal support and a historical reversal area. Daily MACD and RSI classic bullish divergence. Stop = Below reversal area (Look for a close below reversal area). 1st Target = 3/1 R/R 2nd Target = 0.236 fib extension 3rd Target = Resistance / 'B' of butterfly harmonic.

traderken0819

Signals: Terminal flag in Trading range - 3 bottom Buy Divergence on decreasing supply & Increasing demand. Four Month Non Climactic accumulation pattern Entry 2.83 1st target $3 2nd Target $3.25-3.30 3rd Target Retest of 52W Highs Stop Loss- $2.75 **May re-enter on Buy Stop above $3 if stopped out

Master_of_Fine_Charts Premium

This chart looks bullish to me having tested the 200 MA 3x and bouncing off to close above the 78.6% fib level. I think 2.94 will be established as support and the stock will rise up the Fibonacci scale $3.14 is my short-term target. *disclosure: I have no idea what their earnings will be. My opinion is based on the chart alone.

tradingbulls2

High risk= High reward, to be added on russel on june 29- load 2.5c sep

madafakaa

A pullback to 2.77 then a bounce is my expectation.

KozakHlib Premium

Contextual immersion trading strategy idea. Agile Therapeutics, Inc., a women's healthcare company, focuses on the research, development, and commercialization of prescription contraceptive products for women. The demand for shares of the company looks higher than the supply. These and other conditions can cause a rise in the share price in the next days. So I...

MrMercato

Please note: just sharing my view. its not a recommendation for buying or selling

ahudson1

Crossed upper Bollinger Band, and it continued uptrend while testing moving average support levels. I can see it reaching $3.30-$3.50 range in the next 3-5 days.

PennyStock101 Premium

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.

PennyStock101 Premium

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patch. Its lead product candidate, Twirla, also known as AG200-15, is an investigational low-dose, non-daily prescription contraceptive. The company was founded by Chien Te Yen on December 22, 1997 and is headquartered in Princeton, NJ.

cryptorichhh

Take profit 1: 7.50 Take profit 2: 10.00 FDA decision on the companies product Twirla. Womans contraceptive patch BRUDAC ADcomm voted 14-1 in favor. 200mmil marketcap with a 4bill addressable market. Chasing approval since 2013. Approval IS NOT for certain. They could be issued a CRL. Could go much higher on approval. Manage your risk accordingly.

ReversalJerk

• Ticker - AGRX • Entry: 2.93 • Stop loss: 2.74 • Profit target 1: 3.12 • Profit target 2: 3.21

jayce.nugent

This cash strapped company will dilute its shares sooner than later in order to keep itself going. Right now the price is high and at resistance... An opportune time to short !